Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer

NCT00377559 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Neoplasm Metastasis

Interventions

DRUG: Non pegylated liposomal doxorubicin and docetaxel

Sponsor

Catharina Ziekenhuis Eindhoven

Collaborators

[object Object]
[object Object]